Palisade Bio Stock Forward View - Double Exponential Smoothing
| PALI Stock | USD 1.74 0.01 0.58% |
Palisade Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Palisade Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 13th of February 2026 the rsi of Palisade Bio's share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.24) | EPS Estimate Current Year (0.53) | EPS Estimate Next Year (0.23) | Wall Street Target Price 13.4 | EPS Estimate Current Quarter (0.27) |
Using Palisade Bio hype-based prediction, you can estimate the value of Palisade Bio from the perspective of Palisade Bio response to recently generated media hype and the effects of current headlines on its competitors.
The Double Exponential Smoothing forecasted value of Palisade Bio on the next trading day is expected to be 1.73 with a mean absolute deviation of 0.11 and the sum of the absolute errors of 6.84. Palisade Bio after-hype prediction price | USD 1.73 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Palisade Bio to cross-verify your projections. Palisade Bio Additional Predictive Modules
Most predictive techniques to examine Palisade price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Palisade using various technical indicators. When you analyze Palisade charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Palisade Bio Double Exponential Smoothing Price Forecast For the 14th of February 2026
Given 90 days horizon, the Double Exponential Smoothing forecasted value of Palisade Bio on the next trading day is expected to be 1.73 with a mean absolute deviation of 0.11, mean absolute percentage error of 0.02, and the sum of the absolute errors of 6.84.Please note that although there have been many attempts to predict Palisade Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Palisade Bio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Palisade Bio Stock Forecast Pattern
| Backtest Palisade Bio | Palisade Bio Price Prediction | Research Analysis |
Palisade Bio Forecasted Value
In the context of forecasting Palisade Bio's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Palisade Bio's downside and upside margins for the forecasting period are 0.02 and 8.58, respectively. We have considered Palisade Bio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Palisade Bio stock data series using in forecasting. Note that when a statistical model is used to represent Palisade Bio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0229 |
| MAD | Mean absolute deviation | 0.114 |
| MAPE | Mean absolute percentage error | 0.0583 |
| SAE | Sum of the absolute errors | 6.8402 |
Predictive Modules for Palisade Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Palisade Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Palisade Bio After-Hype Price Density Analysis
As far as predicting the price of Palisade Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Palisade Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Palisade Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Palisade Bio Estimiated After-Hype Price Volatility
In the context of predicting Palisade Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Palisade Bio's historical news coverage. Palisade Bio's after-hype downside and upside margins for the prediction period are 0.09 and 8.58, respectively. We have considered Palisade Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Palisade Bio is risky at this time. Analysis and calculation of next after-hype price of Palisade Bio is based on 3 months time horizon.
Palisade Bio Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Palisade Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Palisade Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Palisade Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.06 | 6.85 | 0.01 | 0.00 | 10 Events / Month | 6 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.74 | 1.73 | 0.57 |
|
Palisade Bio Hype Timeline
Palisade Bio is at this time traded for 1.74. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.0. Palisade is expected to decline in value after the next headline, with the price expected to drop to 1.73. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.57%, whereas the daily expected return is at this time at -0.06%. The volatility of related hype on Palisade Bio is about 8353.66%, with the expected price after the next announcement by competition of 1.74. About 48.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.07. Palisade Bio last dividend was issued on the 18th of July 2019. The entity had 1:15 split on the 8th of April 2024. Given the investment horizon of 90 days the next expected press release will be in about 10 days. Check out Historical Fundamental Analysis of Palisade Bio to cross-verify your projections.Palisade Bio Related Hype Analysis
Having access to credible news sources related to Palisade Bio's direct competition is more important than ever and may enhance your ability to predict Palisade Bio's future price movements. Getting to know how Palisade Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Palisade Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ASBP | Aspire BioPharma | (0.20) | 10 per month | 0.00 | (0.19) | 19.52 | (20.19) | 66.08 | |
| CRIS | Curis Inc | (0.02) | 9 per month | 0.00 | (0.04) | 10.62 | (8.13) | 33.70 | |
| ENTO | Entero Therapeutics | 0.09 | 5 per month | 0.00 | (0.02) | 16.86 | (17.06) | 39.61 | |
| PCSA | Processa Pharmaceuticals | (0.06) | 8 per month | 0.00 | (0.03) | 11.68 | (14.08) | 164.28 | |
| BCTX | Briacell Therapeutics Corp | (0.05) | 7 per month | 0.00 | (0.08) | 13.53 | (8.91) | 98.43 | |
| HOTH | Hoth Therapeutics | (0.01) | 8 per month | 0.00 | (0.09) | 5.83 | (5.79) | 13.69 | |
| LPTX | Leap Therapeutics | 0.01 | 9 per month | 6.90 | 0.14 | 25.00 | (9.43) | 65.13 | |
| CTXR | Citius Pharmaceuticals | (0.01) | 10 per month | 0.00 | (0.08) | 11.11 | (9.01) | 38.23 | |
| DARE | Dare Bioscience | (0.03) | 5 per month | 0.00 | (0.03) | 6.55 | (6.98) | 26.52 | |
| ATHA | Athira Pharma | (0.54) | 9 per month | 4.10 | 0.05 | 6.70 | (8.06) | 71.83 |
Other Forecasting Options for Palisade Bio
For every potential investor in Palisade, whether a beginner or expert, Palisade Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Palisade Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Palisade. Basic forecasting techniques help filter out the noise by identifying Palisade Bio's price trends.Palisade Bio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Palisade Bio stock to make a market-neutral strategy. Peer analysis of Palisade Bio could also be used in its relative valuation, which is a method of valuing Palisade Bio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Palisade Bio Market Strength Events
Market strength indicators help investors to evaluate how Palisade Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Palisade Bio shares will generate the highest return on investment. By undertsting and applying Palisade Bio stock market strength indicators, traders can identify Palisade Bio entry and exit signals to maximize returns.
| Accumulation Distribution | 94191.78 | |||
| Daily Balance Of Power | 0.125 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 1.74 | |||
| Day Typical Price | 1.74 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.01 |
Palisade Bio Risk Indicators
The analysis of Palisade Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Palisade Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting palisade stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.74 | |||
| Semi Deviation | 6.47 | |||
| Standard Deviation | 7.05 | |||
| Variance | 49.74 | |||
| Downside Variance | 49.48 | |||
| Semi Variance | 41.9 | |||
| Expected Short fall | (6.41) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Palisade Bio
The number of cover stories for Palisade Bio depends on current market conditions and Palisade Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Palisade Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Palisade Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Palisade Bio Short Properties
Palisade Bio's future price predictability will typically decrease when Palisade Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Palisade Bio often depends not only on the future outlook of the potential Palisade Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Palisade Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.4 M | |
| Cash And Short Term Investments | 9.8 M |
Check out Historical Fundamental Analysis of Palisade Bio to cross-verify your projections. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is there potential for Biotechnology market expansion? Will Palisade introduce new products? Factors like these will boost the valuation of Palisade Bio. Anticipated expansion of Palisade directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Palisade Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Palisade Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Palisade Bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.